相似文献
1
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.
Alzheimers Dement. 2012 Sep;8(5):445-52. doi: 10.1016/j.jalz.2012.08.001.
2
Epidemiology, diagnosis, and management of Alzheimer's disease and related disorders: implications for minority populations.
Health Matrix. 1988;6(4):28-32.
3
Design of comprehensive Alzheimer's disease centers to address unmet national needs.
Alzheimers Dement. 2010 Mar;6(2):150-5. doi: 10.1016/j.jalz.2009.11.004.
4
5
A model for improving the treatment and care of Alzheimer's disease patients through interdisciplinary research.
Alzheimers Dement. 2012 Nov;8(6):564-73. doi: 10.1016/j.jalz.2011.08.005.
6
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21.
7
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
Alzheimers Dement. 2014 Oct;10(5 Suppl):S430-52. doi: 10.1016/j.jalz.2014.08.103.
8
Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium.
Alzheimers Dement. 2022 Oct;18(10):1957-1968. doi: 10.1002/alz.12588. Epub 2022 Feb 20.
9
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30.
10
The health and long-term care policy challenges of Alzheimer's disease.
Aging Ment Health. 2001 May;5 Suppl 1:S138-45.
引用本文的文献
1
Tasks and Activities of an Effective Collaborative Dementia Care Management Program in German Primary Care.
J Alzheimers Dis. 2022;87(4):1615-1625. doi: 10.3233/JAD-215656.
2
NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer's Disease.
Int J Mol Sci. 2021 Oct 27;22(21):11588. doi: 10.3390/ijms222111588.
3
Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease.
Neurosci Bull. 2021 Jul;37(7):1025-1038. doi: 10.1007/s12264-021-00701-z. Epub 2021 May 29.
4
Evaluation of Nootropic Activity of Against Scopolamine-induced Amnesia in Rats.
Turk J Pharm Sci. 2021 Feb 25;18(1):3-9. doi: 10.4274/tjps.galenos.2019.30316.
5
Moderate Mocha Coffee Consumption Is Associated with Higher Cognitive and Mood Status in a Non-Demented Elderly Population with Subcortical Ischemic Vascular Disease.
Nutrients. 2021 Feb 6;13(2):536. doi: 10.3390/nu13020536.
6
Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape.
J Alzheimers Dis. 2020;77(1):339-353. doi: 10.3233/JAD-191300.
7
The value of the GP's clinical judgement in predicting dementia: a multicentre prospective cohort study among patients in general practice.
Br J Gen Pract. 2019 Oct 31;69(688):e786-e793. doi: 10.3399/bjgp19X706037. Print 2019 Nov.
8
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
JAMA. 2019 Apr 2;321(13):1286-1294. doi: 10.1001/jama.2019.2000.
9
Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale.
J Am Med Dir Assoc. 2018 Dec;19(12):1047-1053. doi: 10.1016/j.jamda.2018.07.005. Epub 2018 Aug 23.
10
Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.
Bioinformation. 2018 May 5;14(4):167-180. doi: 10.6026/97320630014167. eCollection 2018.
本文引用的文献
1
The draft "National Plan" to address Alzheimer's disease - National Alzheimer's Project Act (NAPA).
Alzheimers Dement. 2012 May;8(3):234-6. doi: 10.1016/j.jalz.2012.04.004.
2
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Epub 2011 Nov 2.
3
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
Alzheimers Dement. 2012 Jan;8(1):65-73. doi: 10.1016/j.jalz.2011.07.004. Epub 2011 Nov 2.
4
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.
Alzheimers Dement. 2011 Jul;7(4):386-395.e6. doi: 10.1016/j.jalz.2011.05.2243.
5
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.
6
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
7
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.
8
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21.
9
Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.
Alzheimers Dement. 2011 Mar;7(2):127-32. doi: 10.1016/j.jalz.2011.02.005.
10
Revising the definition of Alzheimer's disease: a new lexicon.
Lancet Neurol. 2010 Nov;9(11):1118-27. doi: 10.1016/S1474-4422(10)70223-4. Epub 2010 Oct 9.
Zotero 插件